Skip to content

Top 5 HIV cure and vaccine stories from CROI 2022

Professor Yvonne Bryson (top centre) presenting the HIV remission case at CROI 2022.

Top 5 stories on HIV treatment and care in Africa from CROI 2022

Maya Jackson-Gibson presenting the study on COVID-19 and adverse birth outcomes at CROI 2022.

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

Dr Boris Juelg (bottom left) and Dr Marina Caskey (bottom right) at CROI 2022.

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV

Professor Samir Gupta (top right) at CROI 2022.

Injected PrEP: breakthrough cases could have been detected sooner

Professor Susan Eshleman (top right) at CROI 2022.

Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovirals?

Dr Ilaria Mastrorosa (bottom left) at CROI 2022.

Further evidence that recycling tenofovir in second-line treatment is effective

Dr Lloyd Mulenga (bottom left) and Professor Nick Paton (bottom right) at CROI 2022.

Point-of-care viral load tests did not improve viral suppression in Kenyan children

Dr Rena Patel (bottom right) at CROI 2022.

One person remains undetectable without HIV drugs almost four years after using an antibody-based therapy

Dr Ole Schmeltz Søgaard at CROI 2022.